RADX Radiopharm Theranostics Yalpi foyda marjasi

Radiopharm Theranostics Limited (RADX) kompaniyasining rasmiy ramzlari

Radiopharm Theranostics (RADX) onkologiya uchun innovatsion radiofarmatsevtika vositalarining erta bosqichdagi klinik sinovlariga e'tibor qaratadi. GURU.Markets platformasidagi ushbu grafik sof yalpi marja dinamikasini aks ettiradi, bunda -87.90 qiymati ushbu darajani xarakterlaydi. Radiopharm Theranostics (RADX) B2B yadro tibbiyoti segmentidagi eksklyuziv izotop huquqlariga tayanadi, uning o'sishi esa maqsadli radiatsiya sohasidagi yutuqlar va aniq terapiyaga bo'lgan global qiziqish bilan ta'minlanadi.

radiopharmtheranostics.com - RADX Yalpi marja (davr: 06.12.2024 - 20.11.2026)

Radiopharm Theranostics Limited (RADX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- joriy kotirovkalar va o'rtacha qiymat prognozi:
Kompaniyaning asosiy tahlili:RADX, Radiopharm Theranostics
radiopharmtheranostics.com ishlab chiqargan mahsulot

Radiopharm Theranostics (RADX) kompaniyasining operatsion samaradorligini baholash bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyingi foyda marjasi tahliliga asoslangan bo'lib, bu biznesning fundamental xavfsizlik zaxirasini belgilaydi. Val marjasi tendentsiyasi patentlangan izotoplardan kelajakdagi potentsial pul oqimlarini baholash imkonini beradi, ular radiatsiya terapiyasiga bo'lgan barqaror talab tufayli uzoq muddatli yuqori daromadli manbalarga aylanadi.

Muhim raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik